Arterial heparan sulfate is negatively associated with hyperglycemia and atherosclerosis in diabetic monkeys
Related Experiment Video
Updated: Aug 24, 2026

Preclinical Model of Hind Limb Ischemia in Diabetic Rabbits
Published on: June 2, 2019
Iris J Edwards1, Janice D Wagner, Catherine A Vogl-Willis
1Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1047, USA. iedwards@wfubmc.edu
Background:
Arterial proteoglycans are implicated in the pathogenesis of atherosclerosis by their ability to trap plasma lipoproteins in the arterial wall and by their influence on cellular migration, adhesion and proliferation. In addition, data have suggested an anti-atherogenic role for heparan sulfate proteoglycans and a pro-atherogenic role for dermatan sulfate proteoglycans. Using a non-human primate model for human diabetes, studies examined diabetes-induced changes in arterial proteoglycans that may increase susceptibility to atherosclerosis.
Methods:
Control (n = 7) and streptozotocin-induced diabetic (n = 8) cynomolgous monkeys were assessed for hyperglycemia by measurement of plasma glycated hemoglobin (GHb). Thoracic aortas obtained at necropsy, were extracted with 4 M guanidine HCL and proteoglycans were measured as hexuronic acid. Atherosclerosis was measured by enzymatic analysis of extracted tissue cholesterol. Glycosaminoglycan chains of arterial proteoglycans were released with papain, separated by agarose electrophoresis and analysed by scanning densitometry.
Results:
Tissue cholesterol was positively associated with hexuronic acid content in diabetic arteries (r = .82, p < .025) but not in control arteries. Glycosaminoglycan chain analysis demonstrated that dermatan sulfate was associated with increased tissue cholesterol in both control (r = .8, p < 0.05) and diabetic (r = .8, p < .025) arteries, whereas a negative relationship was observed between heparan sulfate and tissue cholesterol in diabetic arteries only (r = -.7, p < .05). GHb, which was significantly higher in diabetic animals (8.2 +/- 0.9 vs 3.8 +/- 0.2%, p < .0005) was negatively associated with heparan sulfate in diabetic arteries (r = -.7, p < .05).
Conclusions:
These data implicate hyperglycemia induced modifications in arterial proteoglycans that may promote atherosclerosis.
Related Concept Videos
Diabetic Neuropathy
Diabetic Nephropathy
Hyperglycemia
Peripheral Artery Disease I: Introduction
Diabetic Retinopathy
Diabetes: Symptoms, Diagnosis, and Complications